Account
Articles
27.03.2020
NICE postpones technology appraisals

NICE confirmed that they will be prioritising work that is therapeutically critical or relates to ad...

Read more
Articles
18.05.2015
Biosimilar pricing and reimbursement pathways

European payers have not considered biosimilars to be comparable to their reference products or full...

Read more
News
02.10.2014
Incl. latest news on NICE's Value Based Assessment

Updates on the latest news on NICE's Value Based Assessment, as well as the approval of ultra-orphan...

Read more
Newer

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.

Talk to an expert

Remap Consulting have significant experience working with pharmaceutical and biotech companies in helping them navigate global market access.​

Get in touch